Calendar

Immovable lifecycle review calendar

Blue dots are upcoming. Completed reviews turn green for correct thesis, red for wrong thesis, and orange when timing was off.

0

0 post-mortem tasks pending in tasks/pending/

This Month

4

0 upcoming, 4 historical review dates.

Completed

4

Review dates with post-mortems already ingested.

Month View

August 2026

Selected Date

24 Aug 2026

Radico Khaitan

RADICO • REVIEW_COMPLETE • value fundamental

Hold 10 days • Review / exit 24 Aug 2026

-0.32% Post-mortem done
Thesis

Radico is compounding on premiumisation: Q1 FY27 net profit jumped 76% YoY to ₹229.6 cr with a record 20.7% EBITDA margin, Prestige & Above volumes rose 35.8%, and FY27 premium-growth guidance was raised to 25%+. The stock is at a fresh 52-week high (~₹4,499) above all key moving averages with Motilal Oswal Wealth's ₹5,000 target (~11% upside) and a near-debt-free balance sheet.

Prices

Entry: ₹4,651.00

Current: ₹4,636.00

P&L: -0.32%

Hold Plan

Target hold: 10 days

Held so far: 10 days

Review / exit: 24 Aug 2026

Review complete

Assumptions

A1: P&A premium volume growth stays above 20% through Q2-Q3 FY27

A2: Stock holds above the ₹4,230 stop zone over the 10-day hold window

Lifecycle Timeline
Bought 14 Aug 2026

Accepted from analysis task analysis-2026-08-07-0830

Confirmed and held 14 Aug 2026

Day 1 of a 10-day hold at ₹4,675.20 (+0.5% vs entry ₹4,651); fresh 52-week high on record Q1 momentum, but consensus target ₹4,665 is now at price so the remaining upside depends on momentum toward the ₹5,000 pick target.

Reviewed and closed 24 Aug 2026

Post-mortem postmortem-REC-20260814-07-RADICO-2026-08-24 completed on 2026-08-24T03:20:35Z.

Post-Mortem

partially correct

Exit n a
Review Return

Review price: ₹4,636.00

Full hold: -0.32%

Actual: -0.32%

Benchmarks

NIFTY 50: -0.47%

Excess: +0.15%

Sector excess: +3.63%

What If

Held full: -0.32%

Exited at WATCH: +1.76%

Thesis Analysis

Fundamentals delivered as thesis stated (Q1 PAT +76% YoY, record 20.7% EBITDA margin, P&A +35.8%) and the stock held up far better than a FMCG sector de-rating on crude/inflation (-0.32% vs -3.95%). But entry at a 52-week high with consensus target (~₹4,665) at price left ~7% broker-target headroom that never materialized; stock peaked +2% and faded.

Exit Analysis

No exit triggered during the 10-day hold: the ₹5,000 target was never approached and the ₹4,372 stop zone (6%) was never at risk (window low ~₹4,576). Position closed at review on day 10 at -0.32%.

Verified Assumptions
A1 Pending

Not yet verifiable - Q2-Q3 FY27 P&A volume data not released (verify by 2026-11-15). Q1 FY27 P&A volumes of +35.8% and raised 25%+ FY27 premium-growth guidance remain supportive, but no fresh evidence within the hold window.

A2 Verified

Verified: stock never approached the ₹4,230 stop zone. Max adverse excursion was only -1.62% (~₹4,576), and the stock closed the hold window at ₹4,636, well above the stop.

Lessons
high value_fundamental_target_reach_gate

Entering a value_fundamental pick at a fresh 52-week high when the prevailing consensus target is already at/above price (~₹4,665 vs ₹4,651 entry) leaves almost no room for the broker-objective target (₹5,000) to be reached; MFE capped at +2% and the pick closed -0.32%. Require entry price to sit below consensus target by a meaningful margin before accepting broker-objective targets.

moderate value_fundamental_sector_relative_gate

Raw-return misses can hide correct relative calls: RADICO's -0.32% was +0.15pp vs NIFTY (-0.47%) and +3.63pp vs Nifty FMCG (-3.95%) during a crude/inflation-driven FMCG de-rating. Alcobev premiumisation held defensive relative strength, so value_fundamental grading should weigh sector-relative performance, not just absolute move.

Corporate Events

No corporate events attached.